Why is Medicamen Biotec falling/rising?

As of 18-Sep, Medicamen Biotech Ltd's stock price is currently at Rs. 334.00, reflecting a decrease of Rs. 7.5, or 2.2%. The stock has recently hit a new 52-week low of Rs. 329.65 and has underperformed its sector by 3.25%. It is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, investor participation has declined significantly, with delivery volume falling by 40.29% against the 5-day average. The stock's performance over various periods shows a substantial decline, with a year-to-date drop of 34.41% and a 3-year decline of 68.29%, indicating persistent weakness.
In the broader market context, the Sensex has shown positive returns, gaining 1.80% over the past week and 2.14% over the past month, contrasting sharply with Medicamen Biotech's 1-week and 1-month declines of 3.19% and 5.97%, respectively. This divergence suggests that while the overall market is experiencing growth, Medicamen Biotech is struggling significantly. The liquidity of the stock remains adequate for trading, but the overall negative sentiment and poor performance metrics indicate a challenging environment for the company.